INTERNATIONAL PATENT: ELI LILLY AND COMPANY FILES APPLICATION FOR "LEPTIN RECEPTOR AGONISTIC ANTIBODY AS MONO OR COMBO THERAPIES TO TREAT OBESITY"

GENEVA, Sept. 22 -- ELI LILLY AND COMPANY (Lilly Corporate CenterIndianapolis, Indiana 46285) filed a patent application (PCT/US2025/019688) for "LEPTIN RECEPTOR AGONISTIC ANTIBODY AS MONO OR COMBO THERAPIES TO TREAT OBESITY" on Mar 13, 2025. With publication no. WO/2025/193896, the details related to the patent application was published on Sep 18, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AI, Minrong (c/o Eli Lilly and CompanyPO Box 6288Indianapolis, Indiana 46206-6288), CHILTON, Todd C. (c/o Eli Lilly and CompanyPO Box 6288Indianapolis, Indiana 46206-6288), BRIERE, Daniel A. (c/o Eli...